Donor lymphocyte infusion (DLI) post haploidentical stem cell transplantation (Haplo) with post-transplant cyclophosphamide (PTCy): crossing the human leukocyte antigen (HLA) barrier

Arnon Nagler, Panagiotis Tsirigotis*

*Corresponding author for this work

Research output: Contribution to journalComment/debate

2 Scopus citations
Original languageEnglish
Pages (from-to)1640-1641
Number of pages2
JournalBone Marrow Transplantation
Issue number11
StatePublished - Nov 2022

Cite this